1 Result(s)

Article

Absorption, Distribution, Metabolism, and Excretion of [¹⁴C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

Volixibat is a potent inhibitor of the apical sodium-dependent bile acid transporter in development for the treatment of nonalcoholic steatohepatitis. This phase 1, open-label study investigated the absorption...

Nicholas Siebers, Melissa Palmer… in European Journal of Drug Metabolism and Ph… (2018)